Mitomycin and Ondansetron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mitomycin (mitomycin) and Ondansetron (ondansetron). Common drug interactions include arterial thrombosis limb among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Mitomycin and Ondansetron. It is created by eHealthMe based on reports of 92 people who take the same drugs from the FDA, and is updated regularly.

What is Mitomycin?

Mitomycin has active ingredients of mitomycin. eHealthMe is studying from 4,195 Mitomycin users. Check the latest studies of Mitomycin.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,739 Ondansetron users. Check the latest studies of Ondansetron.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

92 people who take Mitomycin and Ondansetron together, and have interactions are studied.

Mitomycin and Ondansetron drug interactions.

What are the common drug interactions of Mitomycin and Ondansetron, by gender? *:

female:

  1. Arterial thrombosis limb (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system-limb)
  2. Blood albumin increased
  3. Blood bilirubin increased
  4. Body temperature increased
  5. Bone pain
  6. Breast cancer
  7. Cardiac arrest
  8. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  9. Creatinine renal clearance decreased
  10. Enterocutaneous fistula

male:

  1. Death
  2. Hypersensitivity
  3. Chronic kidney disease
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Dehydration (dryness resulting from the removal of water)
  7. Depression
  8. Emotional distress
  9. Nocturia (the need to get up in the night to urinate)
  10. Overdose

What are the common drug interactions of Mitomycin and Ondansetron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cardiac arrest
  2. Hypoxia (low oxygen in tissues)
  3. Pericardial effusion (fluid around the heart)
  4. Pulmonary hypertension (increase in blood pressure in the lung artery)
  5. Pulmonary oedema (fluid accumulation in the lungs)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

40-49:

  1. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  2. Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)
  3. Subclavian vein thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Venous thrombosis (blood clot (thrombus) that forms within a vein)
  6. Death
  7. Abdominal pain
  8. Agitation (state of anxiety or nervous excitement)
  9. Blood phosphorus decreased
  10. Chest pain

50-59:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  3. Anion gap increased
  4. Blood bicarbonate decreased
  5. Dehydration (dryness resulting from the removal of water)
  6. Depressed level of consciousness
  7. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  8. Dizziness postural
  9. Drug administration error
  10. Febrile neutropenia (fever with reduced white blood cells)

60+:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Hypersensitivity
  3. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  4. Blood bilirubin increased
  5. Chronic kidney disease
  6. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
  7. Interstitial lung disease
  8. Overdose
  9. Pyrexia (fever)
  10. Alopecia (absence of hair from areas of the body)

What are the existing conditions these people have? *

  1. Breast Cancer: 14 people, 15.22%
  2. Pain: 10 people, 10.87%
  3. Constipation: 9 people, 9.78%
  4. Anal Cancer: 9 people, 9.78%
  5. Hepatocellular Carcinoma (liver cancer): 7 people, 7.61%
  6. Anaesthesia: 5 people, 5.43%

* Approximation only. Some reports may have incomplete information.

Do you take Mitomycin and Ondansetron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mitomycin and Ondansetron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mitomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ondansetron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mitomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ondansetron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mitomycin and ondansetron (the active ingredients of Mitomycin and Ondansetron, respectively), and Mitomycin and Ondansetron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: